# EU-1-09-608_public-assessment-report_20100222_20100222_urorec-epar-public-assessment-report.pdf

eres
European Medicines Agency
Evaluation of Medicines for Human Use
CHMP ASSESSMENT REPORT
FOR
Urorec
London, 10 January 2010
Doc.Ref .: EMA/793234/2009
International Nonproprietary Name: silodosin
Procedure No. EMEA/H/C/001092
7 Westferry Circus, Canary Wharf, London, E14 4HB, UK
Tel. (44-20) 74 18 84 00 Fax (44-20) 75 23 70 51
E-mail: mail@ema.europa.eu
http://www.ema.europa.eu
European Medicines Agency, 2010. Reproduction is authorised provided the source is acknowledged
TABLE OF CONTENTS
Page 2 of 60
1
BACKGROUND INFORMATION ON THE PROCEDURE.
3
1.1
Submission of the dossier
1.2
Steps taken for the assessment of the product.
3
2
SCIENTIFIC DISCUSSION
4
2.1
Introduction.
4
2.2
Quality aspects
5
2.3
Non-clinical aspects.
7
2.4
Clinical aspects
24
2.5
Pharmacovigilance
51
2.6
Overall conclusions, risk/benefit assessment and recommendation
56
3
